Download PDF
Zeitschrift für Orthomolekulare Medizin 2019; 17(02): 5-15
DOI: 10.1055/a-0922-5198
Wissen
© Georg Thieme Verlag KG Stuttgart · New York

Kurzschluss im Nervensystem: Ausgewählte Umweltfaktoren und Mikronährstoffe bei Multipler Sklerose

Uwe Gröber
Further Information

Publication History

Publication Date:
19 July 2019 (online)

    Permissions and Reprints

Zusammenfassung

Als Ursachen für die chronisch entzündliche Autoimmunerkrankung Multiple Sklerose (MS) werden neben einer genetisch bedingten Prädisposition Infektionen und weitere Faktoren wie Rauchen, Übergewicht, Fehlernährung, Stress und Vitamin-D-Mangel diskutiert. Die Ernährung hat über die Darmmikrobiota direkten Einfluss auf die Gesundheit des ZNS. Es zeichnet sich ab, dass eine Ernährung mit ω-3-Fettsäuren und viel Gemüse, Hülsenfrüchten und Vollkornprodukten durch positive Beeinflussung von Darmflora und Darmbarriere bei MS günstig wirkt. Besondere Bedeutung kommt Mikronährstoffen wie Antioxidanzien, Vitamin B12, Biotin und Vitamin A zu.

Schlüsselwörter

Multiple Sklerose - Autoimmunerkrankungen - Umweltfaktoren - Mikronährstoffe - Vitamin-D-Mangel - ω-3-Fettsäuren - Darmbakterien - Mikroglia - Antioxidanzien - Vitamin B12 - Hyperhomocysteinämie - Biotin - Vitamin A
 

  • Literatur

  • 1 Holstiege J, Steffen A, Goffrier B, Bätzing J. Epidemiologie der Multiplen Sklerose – eine populationsbasierte deutschlandweite Studie. Zentralinstitut für die kassenärztliche Versorgung in Deutschland. Versorgungsatlas-Bericht Nr. 17/09, 2017 . doi: 10.20364/VA-17.09
    PubMedGoogle Scholar
  • 2 Goodin DS. The epidemiology of multiple sclerosis: insights to a causal cascade. Handb Clin Neurol 2016; 138: 173-206
    PubMedGoogle Scholar
  • 3 Reich DS, Lucchinetti CF, Calabresi PA. Multiple Sclerosis. N Engl J Med 2018; 378 (02) : 169-180
    CrossrefPubMedGoogle Scholar
  • 4 Lehmann PV, Rottlaender A, Kuerten S. The autoimmune pathogenesis of multiple sclerosis. Pharmazie 2015; 70 (01) : 5-11
    Google Scholar
  • 5 Amato MP, Derfuss T, Hemmer B. et al. Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop. Mult Scler 2017; Jan 6: 1352458516686847 . doi: 10.1177/1352458516686847
    Google Scholar
  • 6 Guan Y, Jakimovski D, Ramanathan M. et al. The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to in vivo imaging. Neural Regen Res 2019; 14 (03) : 373-386
    CrossrefPubMedGoogle Scholar
  • 7 Kleinewietfeld M, Manzel A, Titze J. et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 2013; 496 (7446): 518-522
    Google Scholar
  • 8 Handel AE, Williamson AJ, Disanto G. et al. Smoking and multiple sclerosis: An updated meta-analysis. PLoS One 2011; 6 (01) : 16149 . doi: 10.1371/journal.pone.0016149
    CrossrefPubMedGoogle Scholar
  • 9 Pierrot-Deseilligny C, Souberbielle JC. Vitamin D and multiple sclerosis: An update. Mult Scler Relat Disord 2017; 14: 35-45
    CrossrefPubMedGoogle Scholar
  • 10 Ascherio A, Munger KL, White R. et al. Vitamin D as an early predictor of multiple sclerosis activity and progression. JAMA Neurol 2014; 71 (03) : 306-314
    CrossrefPubMedGoogle Scholar
  • 11 Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 2002; 21 (06) : 495-505
    CrossrefPubMedGoogle Scholar
  • 12 Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood) 2008; 233 (06) ): 674-688
    CrossrefPubMedGoogle Scholar
  • 13 La Rosa F, Clerici M, Ratto D. et al. The Gut-Brain Axis in Alzheimer’s Disease and Omega-3. A Critical Overview of Clinical Trials. Nutrients 2018; 10 (09) . pii: E1267 . doi: 10.3390/nu10091267
    CrossrefPubMedGoogle Scholar
  • 14 Menni C, Zierer J, Pallister T. et al. Omega-3 fatty acids correlate with gut microbiome diversity and production of N-carbamylglutamate in middle aged and elderly women. Sci Rep 2017; 7 (01) : 1079
    CrossrefPubMedGoogle Scholar
  • 15 Swank RL, Dugan BB. Effect of low saturated fat diet in early and late cases of multiple sclerosis. Lancet 1990; 336 (8706): 37-39
    CrossrefPubMedGoogle Scholar
  • 16 Herieka M, Erridge C. High-fat meal induced postprandial inflammation. Mol Nutr Food Res 2014; 58 (01) : 136-146
    CrossrefPubMedGoogle Scholar
  • 17 Teeman CS, Kurti SP, Cull BJ. et al. Postprandial lipemic and inflammatory responses to high-fat meals: a review of the roles of acute and chronic exercise. Nutr Metab (Lond) 2016; 13: 80 . eCollection 2016.
    CrossrefPubMedGoogle Scholar
  • 18 Haghikia A, Jörg S, Duscha A. et al. Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine. Immunity 2015; 43 (04) : 817-829
    CrossrefPubMedGoogle Scholar
  • 19 Gold R. Multiple Sclerosis – Role of environmental Factors and Nutrition. Akt Neurol 2015; 42: 501-502
    Article in Thieme ConnectGoogle Scholar
  • 20 Esposito S, Bonavita S, Sparaco M. et al. The role of diet in multiple sclerosis: A review. Nutr Neurosci 2018; 21 (06) : 377-390
    CrossrefPubMedGoogle Scholar
  • 21 Bagur MJ, Murcia MA, Jiménez-Monreal AM. et al. Influence of Diet in Multiple Sclerosis: A Systematic Review. Adv Nutr 2017; 8 (03) : 463-472
    CrossrefPubMedGoogle Scholar
  • 22 Vitagione P, Mennella I, Ferracane R. et al. Whole-grain wheat consumption reduces inflammation in a randomized controlled trial on overweight and obese subjects with unhealthy dietary and lifestyle behaviors: role of polyphenols bound to cereal dietary fiber. Am J Clin Nutr 2015; 101 (02) : 251-261
    CrossrefPubMedGoogle Scholar
  • 23 Shinto L, Marracci G, Baldauf-Wagner S. et al. Omega-3-fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis. Prostaglandins Leukot Essent Fatty Acids 2009; 80 (2-3): 131-136
    CrossrefPubMedGoogle Scholar
  • 24 Ramirez-Ramirez V, Macias-Isalas MA, Ortiz G. et al. Efficacy of fish oil on serum of TNF-α, IL-1 β, and IL-6 oxidative stress markers in multiple sclerosis treated with interferon beta-1b. Oxid Med Cell Longev 2013; 2013: 709493 . doi: 10.1155/2013/709493
    PubMedGoogle Scholar
  • 25 Beckett JM, Bird ML, Pittaway JK, Ahuja KD. Diet and Multiple Sclerosis: Scoping Review of Web-Based Recommendations. Interact J Med Res 2019; 8 (01) : e10050
    CrossrefPubMedGoogle Scholar
  • 26 Allison DB, Bassaganya-Riera J, Burlingame B. et al. Goals in Nutrition Science 2015-2020. Front Nutr 2015; 2: 26
    PubMedGoogle Scholar
  • 27 Fleck AK, Schuppan D, Wiendl H, Klotz L. Gut-CNS-Axis as Possibility to Modulate Inflammatory Disease Activity-Implications for Multiple Sclerosis. Int J Mol Sci 2017; 18 (07) . pii: E1526. doi: 10.3390/ijms18071526
    CrossrefPubMedGoogle Scholar
  • 28 Mayer EA, Tillisch K, Gupta A. Gut/brain axis and the microbiota. J Clin Invest 2015; 125 (03) : 926-938
    CrossrefPubMedGoogle Scholar
  • 29 David LA, Maurice CF, Carmody RN. et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014; 505 (7484): 559-563
    CrossrefPubMedGoogle Scholar
  • 30 Smits SA, Leach J, Sonnenburg ED. et al. Seasonal cycling in the gut microbiome of the Hadza hunter-gatherers of Tanzania. Science 2017; 357 (6353): 802-806
    CrossrefPubMedGoogle Scholar
  • 31 Calvo-Barreiro L, Eixarch H, Montalban X, Espejo C. Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosis. Autoimmun Rev 2018; 17 (02) : 165-174
    CrossrefPubMedGoogle Scholar
  • 32 Bravo JA, Forsythe P, Chew MV. et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A 2011; 108 (38) : 16050-16055
    CrossrefPubMedGoogle Scholar
  • 33 Tilg H, Moschen AR, Kaser A. Obesity and the microbiota. Gastroenterology 2009; 136 (05) : 1476-1483
    CrossrefPubMedGoogle Scholar
  • 34 Wu GD, Chen J, Hoffmann C. et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011; 334 (6052): 105-108
    CrossrefPubMedGoogle Scholar
  • 35 Cosorich I, Dalla-Costa G, Sorini C. et al. High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis. Sci Adv 2017; 3 (07) : e1700492 . doi: 10.1126/sciadv.1700492
    CrossrefPubMedGoogle Scholar
  • 36 Erny D, Hrabě de Angelis AL, Jaitin D. et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci 2015; 18 (07) : 965-977
    CrossrefPubMedGoogle Scholar
  • 37 Weinstein LI, Revuelta A, Pando RH. Catecholamines and acetylcholine are key regulators of the interaction between microbes and the immune system. Ann N Y Acad Sci 2015; 1351: 39-51
    CrossrefPubMedGoogle Scholar
  • 38 Berer K, Gerdes LA, Cekanaviciute E. et al. Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice. Proc Natl Acad Sci U S A 2017; 114 (40) : 10719-10724
    CrossrefPubMedGoogle Scholar
  • 39 Christ A, Günther P, Lauterbach MAR. et al. Western Diet Triggers NLRP3-Dependent Innate Immune Reprogramming. Cell 2018; 172 (1-2): 162-175
    CrossrefPubMedGoogle Scholar
  • 40 Tasset I, Agüera E, Sánchez-López F. et al. Peripheral oxidative stress in relapsing-remitting multiple sclerosis. Clin Biochem 2012; 45 (06) : 440-444
    CrossrefPubMedGoogle Scholar
  • 41 Wang P, Xie K, Wang C, Bi J. Oxidative stress induced by lipid peroxidation is related with inflammation of demyelination and neurodegeneration in multiple sclerosis. Eur Neurol 2014; 72 (3–4): 249-254
    CrossrefPubMedGoogle Scholar
  • 42 Socha K, Kochanowicz J, Karpioska E. et al. Dietary habits and selenium, glutathione peroxidase and total antioxidant status in the serum of patients with relapsing-remitting multiple sclerosis. Nutr J 2014; 13: 62 . doi: 10.1186/1475-2891-13-62
    CrossrefPubMedGoogle Scholar
  • 43 Siotto M, Filippi MM, Simonelli I. et al. Oxidative Stress Related to Iron Metabolism in Relapsing Remitting Multiple Sclerosis Patients With Low Disability. Front Neurosci 2019; 13: 86
    CrossrefPubMedGoogle Scholar
  • 44 Moccia M, Capacchione A, Lanzillo R. et al. Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis. Ther Adv Neurol Disord 2019; 12: 1756286418819074 . doi: 10.1177/1756286418819074
    Google Scholar
  • 45 Solovyev ND. Importance of selenium and selenoprotein for brain function: From antioxidant protection to neuronal signalling. J Inorg Biochem 2015; 153: 1-12
    CrossrefPubMedGoogle Scholar
  • 46 Zhai J, Bo Y, Lu Y. et al. Effects of Coenzyme Q10 on Markers of Inflammation: A Systematic Review and Meta-Analysis. PLoS One 2017; 12 (01) : e0170172 . doi: 10.1371/journal.pone.0170172
    CrossrefPubMedGoogle Scholar
  • 47 Sanoobar M, Eghtesadi S, Azimi A. et al. Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial. Nutr Neurosci 2015; 18 (04) : 169-176
    CrossrefPubMedGoogle Scholar
  • 48 Gröber U, Kisters K, Schmidt J. Neuroenhancement with Vitamin B12: Underestimated neurological significance. Nutrients 2013; 5 (12) : 5031-5045
    CrossrefPubMedGoogle Scholar
  • 49 Dardiotis E, Arseniou S, Sokratous M. et al. Vitamin B12, folate, and homocysteine levels and multiple sclerosis: A Meta-analysis. Mult Scler Relat Disord 2017; 17: 190-197
    CrossrefPubMedGoogle Scholar
  • 50 Fahmy EM, Elfayoumy NM, Abdelalim AM. et al. Relation of serum levels of homocysteine, vitamin B12 and folate to cognitive functions in multiple sclerosis patients. Int J Neurosci 2018 . doi: 10.1080/00207454.2018.1435538
    PubMedGoogle Scholar
  • 51 Gröber U. Mikronährstoffe. Metabolic Tuning – Prävention – Therapie. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 2011
    Google Scholar
  • 52 Alfadhel M, Tabarki B. SLC19A3 Gene Defects Sorting the Phenotype and Acronyms: Review. Neuropediatrics 2018; 49 (02) : 83-92
    Article in Thieme ConnectPubMedGoogle Scholar
  • 53 Sedel F, Challe G, Vignal C. et al. A novel biotin sensitive leukodystrophy. J Inherit Metab Dis 2011; 34: S267
    Google Scholar
  • 54 Sedel F, Papeix C, Bellanger A. et al. High doses of biotin in chronic progressive multiple sclerosis: a pilot study. Mult Scler Relat Disord 2015; 4 (02) : 159-169
    CrossrefPubMedGoogle Scholar
  • 55 Tourbah A, Lebrun-Frenay C, Edan G. et al. MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study. Mult Scler 2016; 22 (13) : 1719-1731
    CrossrefPubMedGoogle Scholar
  • 56 Mock DM. Biotin: From Nutrition to Therapeutics. J Nutr 2017; 147 (08) : 1487-1492
    CrossrefPubMed
  • 57 Spain R, Powers K, Murchison C. et al. Lipoic acid in secondary progressive MS: A randomized controlled pilot trial. Neurol Neuroimmunol Neuroinflamm 2017; 4 (05) : e374
    CrossrefPubMedGoogle Scholar
  • 58 Bittner F, Murchison C, Koop D. et al. Lipoic Acid Pharmacokinetics at Baseline and 1 year in Secondary Progressive MS. Neurol Neuroimmunol Neuroinflamm 2017; 4 (05) : e380
    CrossrefPubMedGoogle Scholar
  • 59 Bitarafan S, Saboor-Yaraghi A, Sahraian MA. et al. Effect of Vitamin A Supplementation on fatigue and depression in Multiple Sclerosis patients: A Double-Blind Placebo-Controlled Clinical Trial. Iran J Allergy Asthma Immunol 2016; 15 (01) : 13-19
    PubMedGoogle Scholar
  • 60 Fragoso YD, Stoney PN, McCaffery PJ. The evidence for a beneficial role of vitamin A in multiple sclerosis. CNS Drugs 2014; 28 (04) : 291-299
    CrossrefPubMedGoogle Scholar